Literature DB >> 27910768

Pharmacological Properties of Biocompounds from Spores of the Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes): A Review.

Carlos Ricardo Soccol1, Lucas Yamasaki Bissoqui1, Cristine Rodrigues1, Rosalia Rubel2, Sandra R B R Sella3, Fan Leifa4, Luciana Porto de Souza Vandenberghe1, Vanete Thomaz Soccol1.   

Abstract

Ganoderma lucidum is a well-known representative of mushrooms that have been used in traditional Chinese medicine for centuries. New discoveries related to this medicinal mushroom and its biological properties are frequently reported. However, only recently have scientists started to pay special attention to G. lucidum spores. This is in part because of the recent development of methods for breaking the spore wall and extracting biocompounds from the spore. Although some research groups are working with G. lucidum spores, data in the literature are still limited, and the methods used have not been systematized. This review therefore describes the main advances in techniques for breaking the spore wall and extracting biocompounds from the spore. In addition, the major active components identified and their biological properties, such as neurological activity and antiaging and cell-protective effects, are investigated because these are of importance for potential drug development.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27910768     DOI: 10.1615/IntJMedMushrooms.v18.i9.10

Source DB:  PubMed          Journal:  Int J Med Mushrooms        ISSN: 1940-4344            Impact factor:   1.921


  9 in total

1.  Characterizing novel anti-oncogenic triterpenoids from ganoderma.

Authors:  Xiangmin Li; Yizhen Xie; Burton B Yang
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

Review 2.  Traditional uses, chemical components and pharmacological activities of the genus Ganoderma P. Karst.: a review.

Authors:  Li Wang; Jie-Qing Li; Ji Zhang; Zhi-Min Li; Hong-Gao Liu; Yuan-Zhong Wang
Journal:  RSC Adv       Date:  2020-11-18       Impact factor: 4.036

3.  The Possible Role of PD-1 Protein in Ganoderma lucidum-Mediated Immunomodulation and Cancer Treatment.

Authors:  Gan Wang; Le Wang; Jianlong Zhou; Xiaoxin Xu
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

4.  Evaluation of Conditions to Improve Biomass Production by Submerged Culture of Ganoderma sp.

Authors:  Catalina Rosales-López; Alejandro Vargas-López; Mariana Monge-Artavia; Miguel Rojas-Chaves
Journal:  Microorganisms       Date:  2022-07-12

5.  Autotoxicity of Endogenous Organic Acid Stress in Two Ganoderma lucidum Cultivars.

Authors:  Pan Zou; Yongze Guo; Shu Ding; Zhaowei Song; Hanyuan Cui; Yue Zhang; Zhijun Zhang; Xiaoming Chen
Journal:  Molecules       Date:  2022-10-09       Impact factor: 4.927

6.  Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathway.

Authors:  Xiaohui Zhao; Dayu Zhou; Yunen Liu; Chun Li; Xiaoguang Zhao; Ying Li; Wei Li
Journal:  Mol Med Rep       Date:  2017-10-26       Impact factor: 2.952

7.  Ganoderma lucidum spore ethanol extract attenuates atherosclerosis by regulating lipid metabolism via upregulation of liver X receptor alpha.

Authors:  Peng Lai; Xu Cao; Qiao Xu; Yixin Liu; Rui Li; Ju Zhang; Meng Zhang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

8.  Ionic Liquid-Based Ultrasonic-Assisted Extraction Coupled with HPLC and Artificial Neural Network Analysis for Ganoderma lucidum.

Authors:  Changqin Li; Yiping Cui; Jie Lu; Cunyu Liu; Sitan Chen; Changyang Ma; Zhenhua Liu; Jinmei Wang; Wenyi Kang
Journal:  Molecules       Date:  2020-03-13       Impact factor: 4.411

9.  Transcriptional Dynamics of Genes Purportedly Involved in the Control of Meiosis, Carbohydrate, and Secondary Metabolism during Sporulation in Ganoderma lucidum.

Authors:  Manjun Cai; Xiaowei Liang; Yuanchao Liu; Huiping Hu; Yizhen Xie; Shaodan Chen; Xiong Gao; Xiangmin Li; Chun Xiao; Diling Chen; Qingping Wu
Journal:  Genes (Basel)       Date:  2021-03-29       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.